Seasonal Affective Disorder (SAD)
Conditions
Brief summary
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Interventions
DRUGInvestigational Seasonal Affective Disorder (SAD) Drug
Sponsors
GlaxoSmithKline
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(Patient must meet these criteria in order to be eligible for this study.) * Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.
Exclusion criteria
(Patient cannot meet these criteria in order to be eligible for this study.) * Patient has a current or past history of seizure disorder or brain injury. * Patient has a history or current diagnosis of anorexia nervousa or bulimia. * Patient has recurrent summer depression more frequently than winter depression. * Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders. * Patient has initiated psychotherapy within the last 3 months.
Countries
Canada, United States
Outcome results
None listed